These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 4544912)
1. Comparative antifungal activity of hamycin against candida strains complicating tuberculosis. Panse MV; Narayan RA Hindustan Antibiot Bull; 1973 Aug; 16(1):25-8. PubMed ID: 4544912 [No Abstract] [Full Text] [Related]
2. In vitro susceptibility and resistance of Candida spp. to hamycin. Athar MA Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203 [No Abstract] [Full Text] [Related]
3. Preliminary report. Comparative study of pimaricin and fungicidin activity in vitro. Hejzlar M; Výmola F J Hyg Epidemiol Microbiol Immunol; 1970; 14(2):211-3. PubMed ID: 5310409 [No Abstract] [Full Text] [Related]
4. A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. Diekema DJ; Messer SA; Hollis RJ; Boyken L; Tendolkar S; Kroeger J; Jones RN; Pfaller MA Diagn Microbiol Infect Dis; 2009 Feb; 63(2):233-6. PubMed ID: 19070452 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of voriconazole against Candida species isolated in Taiwan. Yang YL; Cheng HH; Lo HJ Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436 [TBL] [Abstract][Full Text] [Related]
6. Reduction of drug resistance of mycobacterium tuberculosis after treatment with hamycin. Panse MV; Narayanan RA; Sathe PM Indian J Med Res; 1974 Sep; 62(9):1360-6. PubMed ID: 4216575 [No Abstract] [Full Text] [Related]
7. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003. da Matta DA; de Almeida LP; Machado AM; Azevedo AC; Kusano EJ; Travassos NF; Salomão R; Colombo AL Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110 [TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis. Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755 [TBL] [Abstract][Full Text] [Related]
10. In vitro interaction of micafungin and fluconazole against Candida. Rodríguez MM; Ruiz M; Pastor FJ; Quindós G; Carrillo A; Guarro J J Antimicrob Chemother; 2007 Jul; 60(1):188-90. PubMed ID: 17525050 [No Abstract] [Full Text] [Related]
11. [Incidence of Candida sp. in patients undergoing kidney transplants]. Ghezzi MC; Giordano A; Cipriani P; Brenciaglia MI Ann Ist Super Sanita; 1982; 18(3):481-3. PubMed ID: 6765080 [No Abstract] [Full Text] [Related]
12. [Investigation of the activity of the preparation cerbiden against Candida spp]. Hladun NP; Bondarenko AS; Nahorna SS; Smyrnova OV Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551 [TBL] [Abstract][Full Text] [Related]
13. Rapid identification of fluconazole resistance using Chrom agar Candida. Verghese SL; Padmaja P; Sutha P; Mathew T; Johni ES Indian J Pathol Microbiol; 2001 Jul; 44(3):305-7. PubMed ID: 12024918 [TBL] [Abstract][Full Text] [Related]
14. Rapid determination of fluconazole susceptibilities for clinical specimens with possible polymicrobial Candida spp. Chiew YF; Inwood H N Z Med J; 2007 Jun; 120(1255):U2567. PubMed ID: 17546112 [No Abstract] [Full Text] [Related]
15. [Characteristics of yeast-like fungi of Candida species isolated from patients in the process of treatment with levorin preparations]. Egorenkova AN; Iarobkova ND Antibiotiki; 1968 Feb; 13(2):181-5. PubMed ID: 5667948 [No Abstract] [Full Text] [Related]
16. [The sensitivity to ketoconazole of Candida strains isolated from the digestive tract ontocenoses in children]. Horwatt-Bozyczko E; Kurnatowski M; Wasowska-Królikowska K; Kurnatowska A Wiad Parazytol; 2001; 47(4):929-33. PubMed ID: 16886449 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of clotrimazole for Candida strains isolated from recent patient samples. Schmidt A Arzneimittelforschung; 1995 Dec; 45(12):1338-40. PubMed ID: 8595097 [TBL] [Abstract][Full Text] [Related]
18. In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology. Szabó Z; Szilágyi J; Tavanti A; Kardos G; Rozgonyi F; Bayegan S; Majoros L Diagn Microbiol Infect Dis; 2009 Jul; 64(3):283-8. PubMed ID: 19394787 [TBL] [Abstract][Full Text] [Related]
19. [Candida lipolytica, a new opportunistic pathogen]. García-Martos P; de la Rubia F; Palomo MJ; Alvarez MM; Marín P; Mira J Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):163. PubMed ID: 8499519 [No Abstract] [Full Text] [Related]
20. Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait. Asadzadeh M; Al-Sweih NA; Ahmad S; Khan ZU Mycoses; 2008 Jul; 51(4):318-23. PubMed ID: 18855844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]